TCG Crossover Management »

BioCryst Pharmaceuticals shares owned by TCG Crossover Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $105M 11M 9.52

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Cogent Biosciences Comm (COGT)
Centessa Pharmaceuticals Adrs (CNTA)
Dianthus Therapeutics Comm (DNTH)
Tyra Biosciences Comm (TYRA)
Immunovant Comm (IMVT)
Biocryst Pharmaceuticals Comm (BCRX)
Mirum Pharmaceuticals Comm (MIRM)
Vor Biopharma Comm (VOR)
Spyre Therapeutics Comm (SYRE)
Amylyx Pharmaceuticals Comm (AMLX)
Disc Medicine Comm (IRON)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
RA Capital Management
Deerfield Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
TCG Crossover Management
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation
Standard Life Aberdeen

View all funds holding BioCryst Pharmaceuticals